UC Davis pathologist Hooman Rashidi is an expert in blood disorders but also a computer programmer. He has married the two disciplines and created must-have learning tools for medical students and residents. His latest is HemeQuiz1, a medical...
14-Feb-2018 4:00 PM EST Add to Favorites
For many, breast cancer is more than just a disease – it’s personal. One in eight women will be diagnosed with breast cancer at some point in their lives.
28-Nov-2017 3:05 PM EST Add to Favorites
In two papers published in the Journal of the National Cancer Institute researchers from UC Davis, UCLA and other institutions have found that peripheral neuropathy, which causes pain, numbness, and tingling in hands and/or feet, can bother...
29-Aug-2017 8:05 AM EDT Add to Favorites
Breast Cancer Surveillance Consortium (BCSC) investigators have received a $17 million program project grant renewal from the National Cancer Institute to study the effectiveness of different breast cancer screening and surveillance strategies using...
19-Jul-2017 6:05 PM EDT Add to Favorites
With its internationally renowned school of veterinary medicine and its NCI-designated comprehensive cancer center, UC Davis is uniquely positioned to harness the power of each to tackle one of life’s greatest challenges: cancer.
6-Jul-2017 2:00 PM EDT Add to Favorites
Second cancers in children and adolescents and young adults (AYA) are far deadlier than they are in older adults and may partially account for the relatively poor outcomes of cancer patients ages 15-39 overall, a new study by UC Davis researchers...
18-Apr-2017 2:00 PM EDT Add to Favorites
In a new study published today in JCI Insight, UC Davis researchers have shown that combining high-intensity focused ultrasound with two immunotherapies (a PD-1 checkpoint inhibitor and TLR9 agonist) can produce excellent response rates in mouse...
23-Mar-2017 3:05 PM EDT Add to Favorites
Recognizing a critical need to improve national vaccination rates for the human papillomavirus (HPV), UC Davis Comprehensive Cancer Center has again united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in issuing a...
17-Jan-2017 2:05 PM EST Add to Favorites
see all news
In a commentary published in the Jan. 4 issue of the New England Journal of Medicine, UC Davis researcher William Murphy expressed cautious optimism about efforts to genetically engineer hematopoietic stem cells (HSCs) to temporarily resist cell...
3-Jan-2018 5:05 PM EST
10-Jan-2017 4:05 PM EST
13-Jul-2016 5:05 PM EDT
8-Jan-2016 7:05 PM EST
7-Jan-2016 1:05 PM EST
20-Oct-2015 12:05 PM EDT
18-May-2015 3:05 PM EDT
1-May-2013 1:00 PM EDTsee all experts